Evidence map›Paper›PMID 41522852›Full record

ArticleClinical case reports2026

A Novel SCNN1B Mutation in a Neonate With Systemic Pseudohypoaldosteronism Type 1: Case Report.

Ensiyeh Bahadoran, Fatemeh Saffari, Sahar Moghbelinejad

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ensiyeh BahadoranCellular and Molecular Research Center Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences Qazvin Iran.
Fatemeh SaffariChildren Growth Research Center Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences Qazvin Iran.
Sahar MoghbelinejadCellular and Molecular Research Center Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences Qazvin Iran.ORCID https://orcid.org/0000-0002-7653-8689

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early recognition of PHA1B in neonates with persistent hyperkalemia and hyponatremia is important for timely intervention. Genetic testing confirms the diagnosis, guiding long-term management. This case highlights a novel SCNN1B mutation, expanding the genetic spectrum and emphasizing the need for lifelong monitoring to prevent life-threatening complications.

Indexed as

aldosteronehyperkalemiahyponatremiapseudohypoaldosteronismreninSCNN1B gene

Identifiers

PMID41522852
PMCPMC12779507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.